Explore the complete record of transactions filed by CARREL MICHAEL H, Chairman & CEO. Officer active across 2 companies, notably AtriCure, Inc.. Cumulatively, 12 filings have been logged. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Michael H. Carrel is President, CEO, and a Director at AtriCure, Inc. and Axonics, Inc. In these roles, he oversees the operations and strategy of the companies, which specialize in medical technologies. Mr. Carrel is responsible for strategic direction and operational management.